Feb 02, 2023 / 05:30PM GMT
Amy Trombly - Sonoma Pharmaceuticals, Inc. - CEO
Thank you for attending the Sonoma Pharmaceuticals presentation. My name is Amy Trombly, I'm the CEO of Sonoma Pharmaceuticals, and I'm here with Chad White who's our CFO. And I'm just going to linger for a couple of minutes on our mandatory legal disclaimers and give you an opportunity to read them if you'd like to.
So a little bit about Sonoma. We've actually been around for a long time, we've been in business for over 20 years. Our main product that we sold over this time is an HOCl product, that has just an amazing assortment of applications, including dermatology, wound care, eye care, nasal care, oral care, animal health, and we've also gotten into disinfectants in certain countries.
HOCl where it's a compound that's been around forever. It's naturally produced in the body. There's an enormous base of knowledge around it, both from Sonoma and from many clinical and KOLs who have studied it.
But the thing to know about HOCl is that it basically kills bugs, viruses, bacteria, fungi. It's antimicrobial, it has anti
Sonoma Pharmaceuticals Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot